Marshall Wace, LLP Quest Diagnostics Inc Transaction History

Marshall Wace, LLP

  • $63.3 Billion
  • Q1 2024

A detailed history of Marshall Wace, LLP transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 586,199 shares of DGX stock, worth $83.2 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
586,199
Previous 168,337 248.23%
Holding current value
$83.2 Million
Previous $23.2 Million 236.18%
% of portfolio
0.12%
Previous 0.04%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$123.78 - $142.11 $51.7 Million - $59.4 Million
417,862 Added 248.23%
586,199 $78 Million
Q4 2023

Feb 14, 2024
BUY
$120.62 - $141.12 $20.1 Million - $23.5 Million
166,348 Added 8363.4%
168,337 $23.2 Million
Q3 2023

Nov 14, 2023
BUY
$121.86 - $144.92 $242,379 - $288,245
1,989 New
1,989 $242,000
Q1 2023

May 15, 2023
SELL
$131.53 - $155.76 $11.9 Million - $14.1 Million
-90,395 Reduced 82.01%
19,827 $2.81 Million
Q4 2022

Feb 14, 2023
BUY
$123.31 - $157.26 $10.6 Million - $13.6 Million
86,337 Added 361.47%
110,222 $17.2 Million
Q3 2022

Nov 14, 2022
BUY
$121.77 - $141.1 $862,740 - $999,693
7,085 Added 42.17%
23,885 $2.93 Million
Q2 2022

Aug 15, 2022
SELL
$127.07 - $145.39 $3.94 Million - $4.51 Million
-30,991 Reduced 64.85%
16,800 $2.23 Million
Q1 2022

May 16, 2022
BUY
$129.09 - $164.35 $1.21 Million - $1.54 Million
9,389 Added 24.45%
47,791 $6.54 Million
Q4 2021

Feb 14, 2022
SELL
$140.36 - $173.01 $8.14 Million - $10 Million
-57,992 Reduced 60.16%
38,402 $6.64 Million
Q3 2021

Nov 15, 2021
BUY
$132.95 - $158.0 $109,284 - $129,876
822 Added 0.86%
96,394 $14 Million
Q2 2021

Aug 13, 2021
BUY
$126.66 - $141.48 $7.83 Million - $8.75 Million
61,828 Added 183.23%
95,572 $12.6 Million
Q1 2021

May 17, 2021
SELL
$114.63 - $133.34 $3.16 Million - $3.67 Million
-27,558 Reduced 44.95%
33,744 $4.33 Million
Q4 2020

Feb 16, 2021
BUY
$112.7 - $128.05 $6.91 Million - $7.85 Million
61,302 New
61,302 $7.31 Million
Q3 2020

Nov 16, 2020
SELL
$107.05 - $130.01 $17.2 Million - $20.9 Million
-160,517 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$73.34 - $122.61 $36.4 Million - $60.9 Million
-496,688 Reduced 75.58%
160,517 $18.3 Million
Q1 2020

May 15, 2020
SELL
$75.14 - $115.68 $3.69 Million - $5.68 Million
-49,135 Reduced 6.96%
657,205 $52.8 Million
Q4 2019

Feb 14, 2020
SELL
$100.29 - $107.99 $6.15 Million - $6.62 Million
-61,309 Reduced 7.99%
706,340 $75.4 Million
Q3 2019

Nov 14, 2019
BUY
$97.85 - $107.42 $48.5 Million - $53.3 Million
496,119 Added 182.71%
767,649 $82.2 Million
Q2 2019

Aug 14, 2019
BUY
$85.18 - $101.94 $2.21 Million - $2.64 Million
25,916 Added 10.55%
271,530 $27.6 Million
Q1 2019

May 14, 2019
SELL
$80.68 - $89.92 $19.2 Million - $21.4 Million
-238,045 Reduced 49.22%
245,614 $22.1 Million
Q4 2018

Feb 14, 2019
SELL
$79.75 - $108.38 $83.1 Million - $113 Million
-1,041,900 Reduced 68.3%
483,659 $40.3 Million
Q3 2018

Nov 14, 2018
BUY
$105.42 - $114.99 $82.4 Million - $89.9 Million
781,703 Added 105.09%
1,525,559 $165 Million
Q2 2018

Aug 14, 2018
BUY
$97.35 - $113.14 $68.8 Million - $80 Million
706,933 Added 1914.61%
743,856 $81.8 Million
Q1 2018

May 15, 2018
BUY
$96.42 - $107.88 $2.28 Million - $2.55 Million
23,647 Added 178.12%
36,923 $3.7 Million
Q4 2017

Feb 14, 2018
BUY
$90.86 - $100.24 $538,254 - $593,821
5,924 Added 80.58%
13,276 $1.31 Million
Q3 2017

Nov 13, 2017
BUY
$91.96 - $108.35 $676,089 - $796,589
7,352
7,352 $691,000

Others Institutions Holding DGX

# of Institutions
870
Shares Held
95.9M
Call Options Held
983K
Put Options Held
436K
View Full List

About QUEST DIAGNOSTICS INC

DGX Quotes by TradingView
  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $16.2B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email